In October 2019, the Honorable Minister of State for Health, Doctor (Senator) Adeleke O. Mamora and leaders from the National Hospital Abuja celebrated the initiative.
Transform our go-to-market model

Improving Chemotherapy Access in Nigeria

In October 2019, the Honorable Minister of State for Health, Doctor (Senator) Adeleke O. Mamora and leaders from the National Hospital Abuja celebrated the initiative.

The Nigerian Ministry of Health, in partnership with Pfizer, the Clinton Health Access Initiative (CHAI), American Cancer Society (ACS) and others, launched the Chemotherapy Access Partnership to deliver lifesaving chemotherapy medicines in seven teaching hospitals across Nigeria. The program gives Nigerians access to lower-priced, high-quality chemotherapy medications – the same ones available today in the developed world – to help address the estimated 100,000 cases and 70,000 deaths due to cancer in the country each year.1

This is the first major government-backed initiative under Pfizer's ground-breaking access agreement with CHAI and ACS, which offers access to high-quality Pfizer chemotherapy medications at almost 50% lower cost in Nigeria, Kenya, Ethiopia, Rwanda, Tanzania, Uganda, Zambia, Zimbabwe and Malawi.

Unleash the power of our people
Deliver first-in-class science
Transform our go-to-market model
Win the digital race in pharma
Lead the conversation